Altimmune Stock

Altimmune P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Altimmune (ALT) as of Jul 24, 2026 is -8.12. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -6.87 — a change of 18.23% (lower).

P/CF

-8.12

YoY

18.23%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Altimmune is 2026 -8.12 . P/CF (Price-to-Cash-Flow Ratio) of Altimmune was 2025 -6.87 . It decreases by 18.23% lower compared to the previous year.
Access this data via the Eulerpool API

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

P/CF (Price-to-Cash-Flow Ratio) of Altimmune is -8.12 in 2026.

Access this data via the Eulerpool API

Valuation — Altimmune

All Key Metrics — Altimmune